Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ringe

Showing results (151-160 of 286) with videos related to

Pageof 29
Sort By:
Transplantation Proceedings|August 15, 2002
Therapeutic drug monitoring of tacrolimus early after liver transplantationF Braun, B Peters, E Schütz, et al.
Transplantation Proceedings|December 20, 2000
An ex vivo model to study the intestinal biotransformation of immunosuppressive drugsF Braun, U Christians, S Laabs, et al.
Transplantation Proceedings|December 20, 2000
An ex vivo model to study the intestinal biotransformation of immunosuppressivesF Braun, U Christians, S Laabs, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Rejection and nephrotoxicity. Diagnostic problems with cyclosporine in renal transplantationR Pichlmayr, K Wonigeit, B Ringe, et al.
Transplantation Proceedings|August 1, 1990
Assessment of liver function in the early postoperative period after liver transplantation with ICG, MEGX, and GAL testsP Lamesch, B Ringe, M Oellerich, et al.
Transplantation Proceedings|June 1, 1988
Four years' experience with cyclosporine A in pediatric kidney transplantationP F Hoyer, G Offner, B S Oemar, et al.
Transplantation Proceedings|March 20, 1999
Is a fatty liver dangerous for transplantation?R Canelo, F Braun, B Sattler, et al.
Transplantation Proceedings|February 1, 1995
Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipientsM Loss, M Winkler, A Schneider, et al.
Journal of Inherited Metabolic Disease|January 1, 1991
Treatment of inherited metabolic disorders by liver transplantationM Burdelski, B Rodeck, A Latta, et al.
Transplantation Proceedings|June 24, 1998
Is liposomal amphotericin B (ambisome) an effective prophylaxis of mycotic infections after liver transplantation?F Braun, R Rüchel, T Lorf, et al.
Pageof 29

Showing results (151-160 of 286) with videos related to

Sort By:
Pageof 29
Transplantation Proceedings|August 15, 2002
Therapeutic drug monitoring of tacrolimus early after liver transplantationF Braun, B Peters, E Schütz, et al.
Transplantation Proceedings|December 20, 2000
An ex vivo model to study the intestinal biotransformation of immunosuppressive drugsF Braun, U Christians, S Laabs, et al.
Transplantation Proceedings|December 20, 2000
An ex vivo model to study the intestinal biotransformation of immunosuppressivesF Braun, U Christians, S Laabs, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Rejection and nephrotoxicity. Diagnostic problems with cyclosporine in renal transplantationR Pichlmayr, K Wonigeit, B Ringe, et al.
Transplantation Proceedings|August 1, 1990
Assessment of liver function in the early postoperative period after liver transplantation with ICG, MEGX, and GAL testsP Lamesch, B Ringe, M Oellerich, et al.
Transplantation Proceedings|June 1, 1988
Four years' experience with cyclosporine A in pediatric kidney transplantationP F Hoyer, G Offner, B S Oemar, et al.
Transplantation Proceedings|March 20, 1999
Is a fatty liver dangerous for transplantation?R Canelo, F Braun, B Sattler, et al.
Transplantation Proceedings|February 1, 1995
Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipientsM Loss, M Winkler, A Schneider, et al.
Journal of Inherited Metabolic Disease|January 1, 1991
Treatment of inherited metabolic disorders by liver transplantationM Burdelski, B Rodeck, A Latta, et al.
Transplantation Proceedings|June 24, 1998
Is liposomal amphotericin B (ambisome) an effective prophylaxis of mycotic infections after liver transplantation?F Braun, R Rüchel, T Lorf, et al.
Pageof 29